Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment. | Cancers (Basel) | 2023 | 37958467 | PubTator, text mining | PubMed |
| IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. | Nat Med | 2023 | 37957373 | PubTator, text mining | PubMed |
| Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. | Front Oncol | 2023 | 37941546 | PubTator, text mining | PubMed |
| Characterization of polarization states of canine monocyte derived macrophages. | PLoS One | 2023 | 37939066 | PubTator, text mining | PubMed |
| A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer. | Fluids Barriers CNS | 2023 | 37924145 | PubTator, text mining | PubMed |
| SUCLG2 Regulates Mitochondrial Dysfunction through Succinylation in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 37904651 | PubTator, text mining | PubMed |
| HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37899135 | PubTator, text mining | PubMed |
| Biomarkers in Systemic Sclerosis: An Overview. | Curr Issues Mol Biol | 2023 | 37886934 | PubTator, text mining | PubMed |
| Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC. | Aging (Albany NY) | 2023 | 37870748 | PubTator, text mining | PubMed |
| Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. | J Inflamm Res | 2023 | 37868834 | PubTator, text mining | PubMed |
| Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling. | Nat Commun | 2023 | 37863913 | PubTator, text mining | PubMed |
| A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. | Nat Commun | 2023 | 37863876 | PubTator, text mining | PubMed |
| Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis. | iScience | 2023 | 37860753 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Value and Immune Infiltration of TFAP2 Family Members in Bladder Cancer from Database and FFPE Sample. | J Cancer | 2023 | 37859819 | PubTator, text mining | PubMed |
| Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study. | BMC Cancer | 2023 | 37858067 | PubTator, text mining | PubMed |
| Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma. | Eur J Med Res | 2023 | 37848987 | PubTator, text mining | PubMed |
| New insights into intestinal macrophages in necrotizing enterocolitis: the multi-functional role and promising therapeutic application. | Front Immunol | 2023 | 37841247 | PubTator, text mining | PubMed |
| CRFB5a, a Subtype of Japanese Eel (Anguilla japonica) Type I IFN Receptor, Regulates Host Antiviral and Antimicrobial Functions through Activation of IRF3/IRF7 and LEAP2. | Animals (Basel) | 2023 | 37835763 | PubTator, text mining | PubMed |
| MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance. | Int J Mol Sci | 2023 | 37834449 | PubTator, text mining | PubMed |
| Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment. | Int J Mol Sci | 2023 | 37834408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=15